ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

ClinicalTrials.gov ID: NCT03785964

Public ClinicalTrials.gov record NCT03785964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Study identification

NCT ID
NCT03785964
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SpringWorks Therapeutics, Inc.
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

  • Nirogacestat oral tablet Drug
  • Placebo Oral Tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 16, 2019
Primary completion
Apr 6, 2022
Completion
Oct 16, 2024
Last update posted
Jan 30, 2025

2019 – 2024

United States locations

U.S. sites
34
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Ronald Regan UCLA Medical Center Los Angeles California 90095
Stanford Cancer Center Palo Alto California 94304
UCSF Mission Bay San Francisco California 94158
Sarcoma Oncology Research Center Santa Monica California 90403
University of Colorado Hospital-Anschutz Cancer Pavilion (ACP) Aurora Colorado 80045
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510
Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
Mayo Clinic Florida Jacksonville Florida 32224
Sylvester Comprehensive Cancer Center Miami Florida 33136
Northwestern Memorial Hospital Chicago Illinois 60611
Johns Hopkins Hospital Baltimore Maryland 21287
Massachusetts General Hosptial (MGH) Boston Massachusetts 02114
Dana-Farber Cancer Institute (DFCI) Boston Massachusetts 02215
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Northwell Health Lake Success New York 11042
Columbia University Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
DUMC/Duke Cancer Center Durham North Carolina 27710
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Oregon Health & Science University-Center for Health & Healing Portland Oregon 97201
Abramson Cancer Center at Pennsylvania Hospital Philadelphia Pennsylvania 19106
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232
Henry-Joyce Cancer Clinic Nashville Tennessee 37232
UT Southwestern Medical Center Dallas Texas 75390
The University of Texas MD Anderson Cancer Center Houston Texas 77030
Seattle Cancer Care Alliance Seattle Washington 98109
University of Wisconsin Clinical Science Center Madison Wisconsin 53792
Froedtert Hospital & the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03785964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03785964 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →